Abstract
We examined the association between risk of sporadic amyotrophic lateral sclerosis (ALS) and seroprevalence of antibodies to echovirus-7 (echo-7) and herpesviruses 6, 7, and 8 through a population-based case–control study. We enrolled in a northern Italy area 20 newly diagnosed ALS cases and 20 referents. Risk of ALS was higher in subjects seropositive for echo-7 when we used the immunofluorescent assay, while little increase was noted with the neutralization test. Considering the different characteristics of these two serological assays, these results suggest an association between disease risk and infection with enterovirus (EV) family members (not specifically echo-7). ALS risk was slightly associated with seropositivity of human herpesvirus-6 (odds ratio: 3.2; p = 0.102) and more strongly with human herpesvirus-8 seropositivity (odds ratio: 8.4, p = 0.064), though these point estimates were statistically unstable due to the limited number of observed cases. The findings of this study warrant further investigation in larger studies of the possible etiologic role of EV or herpesvirus infection in sporadic ALS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mitchell JD. Amyotrophic lateral sclerosis: Toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 235–250.
Chio A, Herrero Hernandez E, Discalzi G, et al. Conjugal amyotrophic lateral sclerosis: Suggestion for the implication of environmental factors. Amyotroph Lateral Scler Other Motor Neuron Disord 2001; 2: 165–166.
Salazar-Grueso EF, Roos RP. Amyotrophic lateral sclerosis and viruses. Clin Neurosci 1995-1996; 3: 360–367.
Karpati G, Dalakas MC. Viral hide-and-seek in sporadic ALS: A new challenge. Neurology 2000; 54: 6–7.
Berger MM, Kopp N, Vital C, Redl B, Aymard M, Lina B. Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology 2000; 54: 20–25.
Walker MP, Schlaberg R, Hays AP, Bowser R, Lipkin WI. Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients. Ann Neurol 2001; 49: 249–253.
Bergomi M, Vinceti M, Nacci G, et al. Environmental exposure to trace elements and risk of amyotrophic lateral sclerosis: A population-based case-control study. Environ Res 2002; 89: 116–123.
Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci 1994; 124(Suppl): 96–107.
The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol 1996; 53: 141–147.
Portolani M, Cermelli C, Pietrosemoli P, et al. Isolation of HHV-6-related virusfrom children affected by infectiouss yndrome. Arch Virol 1990; 110: 143–149.
Portolani M, Cermelli C, Mirandola P, Di Luca D. Isolation of human herpesvirus 7 from an infant with febrile syndrome. J Med Virol 1995; 45: 282–283.
Cermelli C, Moroni A, Pietrosemoli P, Pecorari M, Portolani M. IgG antibodies to human herpesvirus-6 (HHV-6) in Italian people. Microbiologica 1992; 15: 57–63.
Cermelli C, Fabio G, Montorsi M, Sabbatini AM, Portolani M. Prevalence of antibodiesto human herpesviruses 6 and 7 in early infancy and age at primary infection. New Microbiol 1996; 19: 1–8.
Giraud P, Beaulieux F, Ono S, Shimizu N, Chazot G, Lina B. Detection of enteroviral sequences from frozen spinal cord samples of Japanese ALS patients. Neurology 2001; 56: 1777–1778.
Cermelli C, Jacobson S. Viruses and multiple sclerosis. Viral Immunol 2000; 13: 255–267.
Woodall CJ, Riding MH, Graham DI, Clements GB. Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disease. Br Med J 1994; 308: 1541–1543.
Krueger GR, Koch B, Leyssens N, et al. Comparison of seroprevalences of human herpesvirus-6 and-7 in healthy blood donorsfrom nine countries. Vox Sang 1998; 75: 193–197.
Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2: 925–928.
Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donorsand lymphoma patientsfrom different regionsof Italy. J Natl Cancer Inst 1998; 90: 395–397.
Sola P, Bedin R, Casoni F, Barozzi P, Mandrioli J, Merelli E. New insights into the viral theory of amyotrophic lateral sclerosis: Study on the possible role of Kaposi's sarcoma-associated virus/human herpesvirus 8. Eur Neurol 2002; 47: 108–112.
Sola P, Merelli E, Levani M, Giovannetti R, Barozzi P. Human herpesvirus6 (HHV-6) in amyotrophic lateral sclerosis: A polymerase chain reaction (PCR) study. Eur J Neurol 1996; 3: 315–318.
Baillargeon J, Deng JH, Hettler E, et al. Seroprevalence of Kaposi's sarcoma-associated herpesvirus infection among blood donorsfrom Texas. Ann Epidemiol 2001; 11: 512–518.
Calabro ML, Sheldon J, Favero A, et al. Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol 1998; 1: 207–213.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cermelli, C., Vinceti, M., Beretti, F. et al. Risk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesviruses and echovirus-7. Eur J Epidemiol 18, 123–127 (2003). https://doi.org/10.1023/A:1023067728557
Issue Date:
DOI: https://doi.org/10.1023/A:1023067728557